← Back to federal legislation
H.R. 4668In committee

End the Vaccine Carveout Act

Introduced: Jul 23, 2025

Latest action date: Jul 23, 2025

Latest development

Referred to the House Committee on Energy and Commerce.

Civixly approval

No ratings yet

0 ratings

Not enough ratings yet. Public approval appears at 5+ ratings.

Your view
0 comments
Congress
119th Congress
Introduced
Jul 23, 2025
Recorded roll calls
0

Status detail: The most advanced recorded stage is committee consideration.

Plain-language overview

What this bill does

End the Vaccine Carveout Act

This bill removes liability protections for manufacturers and administrators for vaccine-related injuries, and removes limitations on bringing civil actions for vaccine-related injuries or seeking compensation, under the National Vaccine Injury Compensation Program (VICP). It also excludes COVID-19 vaccines from liability protections under the Countermeasures Injury Compensation Program (CICP). 

Under current law, the VICP provides compensation for alleged injuries caused by certain routinely administered vaccines. Individuals generally may not file a civil action in court unless a VICP claim is filed and the resulting judgement is rejected. The VICP also limits the types of claims and amount of damages that may be sought (e.g., no liability for unavoidable side effects or failure to directly warn), and it imposes deadlines for filing claims. The bill removes the requirement to first file a claim under the VICP before pursuing a civil action, so individuals alleging vaccine-related injuries may choose to either bring a civil action or utilize the VICP. It also removes the restrictions on the types of civil actions and damages. The bill also removes the deadlines for filing claims under the VICP and applies this change retroactively.

Additionally, under current law, the CICP provides compensation for alleged injuries caused by certain medical countermeasures during public health emergencies, including COVID-19 vaccines. The bill excludes COVID-19 vaccines from being considered as medical countermeasures. Therefore, under the bill, individuals may file civil actions against manufacturers of COVID-19 vaccines rather than filing claims under the CICP.

Official summary from Congress.gov.

Civixly topics

What this legislation is about

Civixly topics make federal and state legislation comparable. They are derived from the official CRS policy area and legislative subjects.

Official CRS policy area

Health

Committee activity

Committees and subcommittees that received, reviewed, marked up, or reported this legislation.

Amendments

Proposed changes to this measure, with their latest official outcome or action from Congress.gov.

No amendments are listed for this measure.

Checked against Congress.gov Oct 11, 2026.

Action timeline

Newest action first. Action language comes from the official Congress.gov record.

View full action timeline3 actions
  1. Introduced in House

    IntroReferralLibrary of Congress
  2. Referred to the House Committee on Energy and Commerce.

    IntroReferralHouse floor actions
  3. Introduced in House

    IntroReferralLibrary of Congress

Roll-call votes

Recorded House and Senate votes connected to this bill. Your representatives appear first when available.

No connected roll-call votes are currently available for this bill.

Discussion

0 comments across 0 threads

Sign in to join the discussion.Comments are publicly visible.

Loading comments...

Sources: Congress.gov and official House and Senate vote records.

View data freshness details

Base metadata check pending · Civixly summary check pending · Action timeline checked Oct 11, 2026 · Complete sponsorship check pending · Topics checked Oct 11, 2026 · Committees checked Oct 11, 2026 · Status checked Oct 11, 2026 · Related bills checked Oct 11, 2026.